CHI3L1 and early-onset autosomal dominant Alzheimer disease: Due to the inability to obtain reliable human neural stem cell lines, we were unable to perform in vitro neurogenesis assays to determine whether CHI3L1 directly suppresses neuronal differentiation, as reported in MS, NMOSD, and Alzheimer's disease models.